REVIEW 2 cited by
Drug Discovery with Dynamic Goal-aware Fragments
Not yet reviewed by Pith; the record is open.
This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.
SPECIMEN: schema-true, not a live event
T0 review · schema-true
One-sentence machine reading of the paper's core claim.
pith:XXXXXXXX · record.json · timestamp
read the original abstract
Fragment-based drug discovery is an effective strategy for discovering drug candidates in the vast chemical space, and has been widely employed in molecular generative models. However, many existing fragment extraction methods in such models do not take the target chemical properties into account or rely on heuristic rules. Additionally, the existing fragment-based generative models cannot update the fragment vocabulary with goal-aware fragments newly discovered during the generation. To this end, we propose a molecular generative framework for drug discovery, named Goal-aware fragment Extraction, Assembly, and Modification (GEAM). GEAM consists of three modules, each responsible for goal-aware fragment extraction, fragment assembly, and fragment modification. The fragment extraction module identifies important fragments contributing to the desired target properties with the information bottleneck principle, thereby constructing an effective goal-aware fragment vocabulary. Moreover, GEAM can explore beyond the initial vocabulary with the fragment modification module, and the exploration is further enhanced through the dynamic goal-aware vocabulary update. We experimentally demonstrate that GEAM effectively discovers drug candidates through the generative cycle of the three modules in various drug discovery tasks. Our code is available at https://github.com/SeulLee05/GEAM.
Forward citations
Cited by 2 Pith papers
-
Conditional Chemical Language Models are Versatile Tools in Drug Discovery
SAFE-T is a single conditional chemical language model that unifies scoring and generation of drug-like molecules from target family, protein, and mechanism-of-action prompts.
-
Why Pool When You Can Flow? Active Learning with GFlowNets
Training a GFlowNet to generate high-BALD molecules gives pool-size-independent acquisition and near-BALD classification quality on JAK2 virtual screening.
Discussion (0). Continue with ORCID to comment.